Annovis Partners With NeuroRPM to Add AI Monitoring in PD Study
MALVERN, PA — Annovis Bio, Inc. (NYSE: ANVS) has partnered with NeuroRPM to integrate an FDA-cleared artificial intelligence platform into its ongoing Parkinson’s disease study to improve symptom monitoring and …
Annovis Partners With NeuroRPM to Add AI Monitoring in PD Study Read More